Across TCGA pan-cancer cohorts, FTH1P23 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated FTH1P23 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher FTH1P23 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FTH1P23 expression acts as an unfavorable survival marker, although some lineages such as DLBC and READ show a favorable association.
KICH, KIRP, and MESO are the cancer types where FTH1P23 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.